Search Results 201-210 of 17517 for ulcerative colitis

1. Vedolizumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Vedolizumab injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is a monoclonal antibody that works ...

2. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

   ... (IBD) has evolved over the last ten years. Evidence now suggests that the most effective therapy early in the course of Crohn's disease (CD) and ulcerative ...

3. Mayo Clinic Radio: IBD / food allergies / Convergence Science Program

   There are two common types: ulcerative colitis, which causes ulcers, or sores, in the lining of the large intestine and rectum, and Crohn's disease, which ...

4. Study of the Effect of SHP647 as Maintenance Treatment in Participants with Moderate to Severe Ulcerative Colitis who Achieved Clinical Response in Induction Studies - Mayo Clinic

   The purpose of this study is to evaluate the efficacy of SHP647 as maintenance therapy in participants with moderate to severe ulcerative colitis (UC) who ...

5. Crohn's Disease Clinical Trials

   The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis or Crohn's ...

6. A 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   A 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis · Overview.

7. Crohn's disease - Doctors and departments - Mayo Clinic

   Colonoscopy, Flexible sigmoidoscopy, Upper endoscopy, Ulcerative colitis, Crohn's disease, Microscopic colitis, Immune-...related adverse event. Show more ...

8. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis. Print details. Share ...

9. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

   ... (IBD) has evolved over the last ten years. Evidence now suggests that the most effective therapy early in the course of Crohn's disease (CD) and ulcerative ...

10. Crohn's disease - Doctors and departments - Mayo Clinic

    Areas of focus: Colonoscopy, Flexible sigmoidoscopy, Upper endoscopy, Ulcerative colitis, Inflammatory bowel disease, Crohn's disease, ...Microscopic colitis, ...